| Patent | Date |
|---|
Method for treating fibrotic liver tissue using Cl-IB-MECA
Grant 11,291,681 - Fishman , et al. April 5, 2 | 2022-04-05 |
An A3 Adenosine Receptor Ligand For Use For Achieving A Fat Loss Effect
App 20220079968 - FARBSTEIN; Motti ; et al. | 2022-03-17 |
A3 Adenosine Receptor Ligand For Managing Cytokine Release Syndrome
App 20210069227 - FISHMAN; Pnina | 2021-03-11 |
A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation
App 20200384009 - FISHMAN; Pnina ; et al. | 2020-12-10 |
Method for treating NASH accompanied by fibrosis using Cl-IB-MECA
Grant 10,780,106 - Fishman , et al. Sept | 2020-09-22 |
Use of A3 adenosine receptor agonist in osteoarthritis treatment
Grant 10,265,337 - Fishman | 2019-04-23 |
A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation
App 20180264022 - FISHMAN; Pnina ; et al. | 2018-09-20 |
A3 adenosine receptor ligands for use in treatment of a sexual dysfunction
Grant 9,549,943 - Fishman January 24, 2 | 2017-01-24 |
Use Of A3 Adenosine Receptor Agonist In Osteoarthritis Treatment
App 20160263142 - FISHMAN; Pnina | 2016-09-15 |
Method for inducing hepatocyte proliferation and uses thereof
Grant 9,387,220 - Fishman , et al. July 12, 2 | 2016-07-12 |
A3 Adenosine Receptor Ligands For Use In Treatment Of A Sexual Dysfunction
App 20150216889 - Fishman; Pnina | 2015-08-06 |
Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N.sup.6-(3-idobenzyl)-adenin-9-yl]-N-methyl-.beta.-D-ribofuro- namide(IB-MECA/CF-101) for treatment of psoriasis
Grant 8,987,228 - Fishman March 24, 2 | 2015-03-24 |
Treatment Of Liver Conditions
App 20150018299 - Fishman; Pnina ; et al. | 2015-01-15 |
Method For Inducing Hepatocyte Proliferation And Uses Thereof
App 20140364388 - FISHMAN; Pnina ; et al. | 2014-12-11 |
Method for inducing hepatocyte proliferation and uses thereof
Grant 8,846,635 - Fishman , et al. September 30, 2 | 2014-09-30 |
Biological Marker For Inflammation
App 20130345163 - FISHMAN; Pnina ; et al. | 2013-12-26 |
A3 adenoside receptor agonists for the reduction of intraocular pressure
Grant 8,557,790 - Fishman , et al. October 15, 2 | 2013-10-15 |
Biological marker for inflammation
Grant 8,541,182 - Fishman , et al. September 24, 2 | 2013-09-24 |
A3ar Agonists For The Treatment Of Uveitis
App 20130045943 - Caspi; Rachel ; et al. | 2013-02-21 |
Pharmaceutical Composition Comprising A3 Adenosine Receptor Agonist (ib-meca/cf-101) For Treatment Of Psoriasis
App 20120165284 - Fishman; Pnina | 2012-06-28 |
A3 Adenoside Receptor Agonists For The Reduction Of Intraocular Pressure
App 20120065155 - Fishman; Pnina ; et al. | 2012-03-15 |
Treatment of dry eye conditions
Grant 7,825,102 - Fishman , et al. November 2, 2 | 2010-11-02 |
Biological Marker For Inflammation
App 20100256084 - Fishman; Pnina ; et al. | 2010-10-07 |
Method For Inducing Hepatocyte Proliferation And Uses Thereof
App 20100249053 - Fishman; Pnina ; et al. | 2010-09-30 |
Treatment For Dry Eye Conditions
App 20100222369 - FISHMAN; Pnina ; et al. | 2010-09-02 |
Use of an adenosine A3 receptor agonist for inhibition of viral replication
Grant 7,589,075 - Fishman , et al. September 15, 2 | 2009-09-15 |
Method for treatment of multiple sclerosis
Grant 7,465,715 - Fishman , et al. December 16, 2 | 2008-12-16 |
Use of A3 Adenosine Receptor Agonist in Osteoarthritis Treatment
App 20080300213 - Fishman; Pnina | 2008-12-04 |
Therapeutic Uses of A3 Adenosine Receptor Antibodies
App 20080292637 - Fishman; Pnina | 2008-11-27 |
Biological Marker for Inflammation
App 20080056992 - Fishman; Pnina ; et al. | 2008-03-06 |
Treatment of Inflammation
App 20080051365 - Fishman; Pnina ; et al. | 2008-02-28 |
Treatment of dry eye conditions
App 20070099865 - Fishman; Pnina ; et al. | 2007-05-03 |
A3AR agonists for the treatment of inflammatory arthritis
Grant 7,141,553 - Fishman November 28, 2 | 2006-11-28 |
Treatment of hyperproliferative disease
App 20060241069 - Fishman; Pnina ; et al. | 2006-10-26 |
Method for treatment of multiple sclerosis
App 20060142237 - Fishman; Pnina ; et al. | 2006-06-29 |
Pharmaceutical compositions having anti-inflammatory activity
App 20050277615 - Fishman, Pnina ; et al. | 2005-12-15 |
Method of treating leukopenia with adenosine
Grant 6,911,435 - Cohn , et al. June 28, 2 | 2005-06-28 |
Method of treating an individual with methyl 1-[N6-(3-iodobenzyl)-adenin-9- -yl] beta-D-ibofuronamide
App 20050101560 - Warrington, Steve ; et al. | 2005-05-12 |
Diagnostic markers for therapeutic treatment
App 20040229246 - Fishman, Pnina ; et al. | 2004-11-18 |
Activation of natural killer cells by adenosine A3 receptor agonists
App 20040204481 - Fishman, Pnina | 2004-10-14 |
Pharmaceutical administration of adenosine agonists
Grant 6,790,839 - Fishman , et al. September 14, 2 | 2004-09-14 |
A3AR agonists for the treatment of inflammatory arthritis
App 20040167094 - Fishman, Pnina | 2004-08-26 |
A3AR as a marker for a diseased state
App 20040137477 - Fishman, Pnina ; et al. | 2004-07-15 |
Use of an adenosine a3 receptor agonist for inhibition of viral replication
App 20040106572 - Fishman, Pnina ; et al. | 2004-06-03 |
Pharmaceutical administration of adenosine agonists
Grant 6,638,914 - Fishman , et al. October 28, 2 | 2003-10-28 |
Adenosine A3 receptor agonist
App 20030143282 - Fishman, Pnina | 2003-07-31 |
Modulation of GSK-3beta activity and its different uses
App 20020165197 - Fishman, Pnina ; et al. | 2002-11-07 |
Modulation of GSK-3beta activity and its different uses
App 20020115635 - Fishman, Pnina ; et al. | 2002-08-22 |
Pharmaceutical use of adenosine agonists
App 20020037871 - Fishman, Pnina ; et al. | 2002-03-28 |
Pharmaceutical use of adenosine agonists
App 20010031742 - Fishman, Pnina ; et al. | 2001-10-18 |
Anti-metastatic factor
Grant 5,242,692 - Djaldetti , et al. September 7, 1 | 1993-09-07 |
| 